anti aging/inflammation

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority under 35 U.S.C. .sctn. 119 to Korean Patent Application No. 10-2017-0050831, filed on Apr. 20, 2017 and Korean Patent Application No. 10-2018-0045029, filed on Apr. 18, 2018, in the Korean Intellectual Property Office, the

TECHNICAL FIELD The present invention relates to an antioxidant, anti-inflammatory or anti-aging composition containing any one or more of a Taxus cambium- or procambium-derived cell line, an extract thereof, a lysate thereof and a culture medium thereof. BACKGROUND ART Aging is a functional,

This application is the U.S. National Phase under 35 U.S.C. .sctn.371 of International Application No. PCT/JP2013/059128, filed Mar. 27, 2013, designating the U.S., and published in Japanese as WO 2013/146943 on Oct. 3, 2013, which claims priority to Japanese Patent Application No. 2012-081177 filed

TECHNICAL FIELD The present invention relates to an anti-aging composition including low-molecular weight hyaluronic acids, high-molecular weight hyaluronic acids and polysaccharides extracted from root bark of Ulmus davidiana. More particularly, the present invention relates to a pharmaceutical or

BACKGROUND OF THE INVENTION This invention relates to herbal compositions. More particularly, this invention relates to an herbal composition capable of reducing inflammation in bones and joints. The present invention further relates to methods of using such herbal composition to reduce

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of Korean Patent Application No. 10-2009-102325, filed on Oct. 27, 2009 in the Korean Intellectual Property Office, which is incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION (a) Field of the

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition and, more particularly, to an anti-aging composition using liposomal technology for more effective absorption by the body. 2. Description of the Related Art Several formulations for anti-aging

BACKGROUND OF THE INVENTION Methylation is the key to the epigenetic perfect expression, peak maintenance and re-assembly of all genes (DNA/RNA). On the skin surface or wound site, methylation can be part of the energy cycle to facilitate in the epigenome's perfect retooling; the Methyl Nicotinate

BACKGROUND OF THE INVENTION Methylation is key to the epigenetic perfect expression, peak maintenance and re-assembly of all genes (DNA/RNA). On the skin surface or wound site, methylation can be part of the energy cycle to facilitate in the epigenome's perfect retooling; the Methyl Nicotinate

CROSS REFERENCE TO RELATED APPLICATIONS Certain ion-pair compositions have been disclosed in unrelated prior applications by this inventor; U.S. patent application Ser. No. 10/249,701 (filed May 1, 2003), Ser. No. 10/439,349 (filed May 15, 2003), and Ser. No. 10/250,045 (filed May 30,

BACKGROUND OF THE INVENTION This invention relates to certain hydroxyaryl alkanols, alkyl amines, alkyl amino acids, alkyl amino esters, alkyl amino alkanols ("Hydroxyaryl compounds"), and their organic and inorganic acid or base salts. The said hydroxyaryl compounds are derived from certain

BACKGROUND OF THE INVENTION The enhancement of physical appearance occupies greater focus in human life than nearly all other daily life-related actions. There are far more consumer products available for the beautification of human body than for the treatment of human ailments. The improvement of

This invention relates to certain divalent and polyvalent d-orbital metals of first transition series of the Periodic Table of Elements, from Group IV to Group VI, and including Molybdenum; which are Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, As, Se, and Mo, and which are complexed concurrently with

FIELD This invention relates to formulations for use in therapeutic and/or cosmetic treatments, particularly those in which a localised disruption in direct cell-cell communication is desirable. BACKGROUND Gap junctions are cell membrane structures which facilitate direct cell-cell communication. A

This application is a U.S. national stage application of International Application No. PCT/GB00/00238, filed Jan. 27, 2000 (published as WO00/44409 on Aug. 3, 2000) and claims the benefit of priority to NZ 333928 (filed Jan. 27, 1999) and NZ 500190 (filed Oct. 7, 1999). The contents of each of which